Charles Schwab Portfolio holdings
Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$2.16B |
| 2 |
Hershey
HSY
|
+$663M |
| 3 |
Lockheed Martin
LMT
|
+$622M |
| 4 |
Altria Group
MO
|
+$525M |
| 5 |
Pfizer
PFE
|
+$499M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$2.76B |
| 2 |
Merck
MRK
|
+$2.35B |
| 3 |
Automatic Data Processing
ADP
|
+$1.57B |
| 4 |
Blackstone
BX
|
+$1.38B |
| 5 |
Illinois Tool Works
ITW
|
+$1.13B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.85% |
| 2 | Financials | 12.71% |
| 3 | Healthcare | 11.72% |
| 4 | Consumer Discretionary | 10.09% |
| 5 | Industrials | 9.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
HSHP
3001
Himalaya Shipping
HSHP
$747M
| $534K | ﹤0.01% |
69,223
+3,605
| +5% | +$26.6K |
|
3002
Grupo Cibest SA
CIB
$21.6B
| $533K | ﹤0.01% |
15,566
-29,493
| -65% | -$957K |
|
3003
Forum Energy Technologies
FET
$779M
| $532K | ﹤0.01% |
26,646
| – | – |
|
3004
Clarus
CLAR
$126M
| $531K | ﹤0.01% |
78,715
| – | – |
|
3005
Zevra Therapeutics
ZVRA
$573M
| $530K | ﹤0.01% |
91,410
-4,720
| -5% | -$29K |
|
3006
Atara Biotherapeutics
ATRA
$76.9M
| $528K | ﹤0.01% |
30,454
+648
| +2% | +$11.5K |
|
3007
Pure Cycle
PCYO
$257M
| $528K | ﹤0.01% |
55,562
+2,403
| +5% | +$23.8K |
|
3008
Hamilton Insurance Group
HG
$3.55B
| $527K | ﹤0.01% |
+37,837
| New | +$549K |
|
3009
Capital Bancorp
CBNK
$619M
| $526K | ﹤0.01% |
25,241
| – | – |
|
|
PHLT
3010
DELISTED
Performant Healthcare Inc
PHLT
| $525K | ﹤0.01% |
178,689
| – | – |
|
3011
National Bankshares
NKSH
$265M
| $525K | ﹤0.01% |
15,718
| – | – |
|
3012
OptimizeRx
OPRX
$121M
| $523K | ﹤0.01% |
43,031
-1,872
| -4% | -$27.1K |
|
3013
The Joint Corp
JYNT
$118M
| $522K | ﹤0.01% |
39,998
| – | – |
|
3014
Mistras Group
MG
$490M
| $522K | ﹤0.01% |
54,631
| – | – |
|
|
BRT
3015
BRT Apartments
BRT
$282M
| $520K | ﹤0.01% |
30,974
-1,834
| -6% | -$30.8K |
|
|
SSBK
3016
DELISTED
Southern States Bancshares
SSBK
| $520K | ﹤0.01% |
20,066
| – | – |
|
3017
Aclaris Therapeutics
ACRS
$739M
| $520K | ﹤0.01% |
419,334
-16,996
| -4% | -$20.3K |
|
3018
Colony Bankcorp
CBAN
$467M
| $517K | ﹤0.01% |
44,958
| – | – |
|
3019
Northeast Community Bancorp
NECB
$371M
| $515K | ﹤0.01% |
32,759
-1,917
| -6% | -$31.1K |
|
3020
Quantum-Si Incorporated
QSI
$162M
| $515K | ﹤0.01% |
261,475
+880
| +0.3% | +$1.54K |
|
3021
Offerpad Solutions
OPAD
$19.4M
| $514K | ﹤0.01% |
6,345
+1,158
| +22% | +$101K |
|
3022
Brookfield Renewable
BEPC
$6.28B
| $513K | ﹤0.01% |
20,889
+796
| +4% | +$20.9K |
|
3023
Concrete Pumping Holdings
BBCP
$498M
| $513K | ﹤0.01% |
64,952
-3,776
| -5% | -$30K |
|
3024
Evolution Petroleum
EPM
$131M
| $512K | ﹤0.01% |
83,448
-4,881
| -6% | -$28K |
|
|
MBCN
3025
DELISTED
Middlefield Banc Corp
MBCN
| $512K | ﹤0.01% |
21,421
| – | – |
|
Similar funds
Charles Schwab's Q1 2024 Portfolio in Review
As of Q1 2024, Charles Schwab held 3,573 positions worth $433B, up 10% from $394B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Trading was light in Q1 2024: portfolio turnover was 3.8%. Charles Schwab opened 35 new positions and exited 102, leaving the 3,573-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 23% a quarter earlier, followed by Financials and Healthcare.
- Charles Schwab's largest Q1 2024 buy was Schwab Fundamental US Large Company Index ETF: 3,608,604 shares worth $81.1M.
- Charles Schwab added most to Bristol-Myers Squibb in Q1 2024, an estimated $2.16B increase.
- Charles Schwab's biggest Q1 2024 reduction was Broadcom, cutting an estimated $2.76B.
- Charles Schwab fully exited Splunk Inc in Q1 2024, selling an estimated $104M.
- Charles Schwab's ten largest holdings make up 20% of its $433B portfolio in Q1 2024.
- Charles Schwab opened 35 new positions and closed 102 in Q1 2024.
- Charles Schwab's portfolio value rose 10% quarter-over-quarter to $433B.
Based on Charles Schwab's 13F filing for Q1 2024, filed 9 May 2024.